AlbertsD.S., DahlbergS., GreenS.J.: Analysis of patient age as an indipendent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stages III (suboptimal) and IV ovarian cancer. Cancer, 71: 618–627, 1993.
2.
ThigpenT., BradyM.F., OmuraG.A.: Age as prognostic factor in ovarian carcinoma. Cancer, 71: 606–614, 1993.
3.
EdmonsonJ.H., SUJ., KrookJ.E.: Treatment of ovarian cancer in elderly women. Cancer, 71: 615–617, 1993.
4.
CeccaroniM., D'AgostinoG., FerrandinaG., GadducciA., Di VagnoG., PignataS.: Gynecologic malignancies in elderly patients: is age 70 a limit to standard-dose chemotherapy? A retrospective toxicity Italian study. Gynaecol Oncol, 2002(in press).
